Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome1 passage
• Ciraparantag, an anticoagulant reversal drug: mechanism of action, pharmacokinetics, and reversal of anticoagulants1 passage
• Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA1 passage
• Incidence and mortality rates of intracranial hemorrhage in hemophilia: a systematic review and meta-analysis1 passage
• Recommendations for the management of hemophagocytic lymphohistiocytosis in adults1 passage
• Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome1 passage